on IKONISYS (EPA:ALIKO)
Aliko Scientific Unveils CYTOfast Auto at MEDICA 2026
Aliko Scientific, a subsidiary of Ikonisys SA, is set to launch its new automated system, CYTOfast Auto, at MEDICA 2026 in Düsseldorf. The liquid-based cytology platform aims to penetrate large laboratories and screening programs within the global cytology market, expected to reach USD 38.2 billion by 2030.
This new system combines Hospitex's proprietary technology with robotics to enhance laboratory efficiency and ensure high-quality sample preparation. It supports Aliko's strategy of expanding its installed base and boosting revenues through continuous sales of reagents and services.
The introduction of CYTOfast Auto positions Aliko Scientific favorably in accessing high-volume facilities and public hospital contracts, supporting their growth in an evolving cytology market.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all IKONISYS news